Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen

Published:2019-04-08 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Wculek Stefanie K.,Amores-Iniesta Joaquín,Conde-Garrosa Ruth,Khouili Sofía C.,Melero Ignacio,Sancho David^ORCID

Funder

Ministerio de Ciencia, Innovación e Universidades

Comunidad de Madrid

Instituto de Salud Carlos III

Fondation Acteria

Fundació la Marató de TV3

FP7 Ideas: European Research Council

European Commission H2020

Fundación Científica Asociación Española Contra el Cáncer

European Molecular Biology Organization

Ministerio de Educación, Cultura y Deporte

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0565-5.pdf

Reference54 articles.

1. Durgeau A, Virk Y, Corgnac S, Mami-Chouaib F. Recent advances in targeting CD8 T-cell immunity for more effective Cancer immunotherapy. Front Immunol. 2018;9:14.

2. Singer M, Wang C, Cong L, Marjanovic ND, Kowalczyk MS, Zhang H, et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells. Cell. 2016;166:1500–11.

3. Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350–5.

4. Whiteside TL, Demaria S, Rodriguez-Ruiz ME, Zarour HM, Melero I. Emerging opportunities and challenges in Cancer immunotherapy. Clin Cancer Res. 2016;22:1845–55.

5. Saxena M, Bhardwaj N. Re-emergence of dendritic cell vaccines for Cancer treatment. Trends Cancer. 2018;4:119–37.

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy;Journal of Controlled Release;2024-09

2. Immunometabolic characteristics of Dendritic Cells and its significant modulation by mitochondria-associated signaling in the tumor microenvironment influence cancer progression;Biochemical and Biophysical Research Communications;2024-09

3. Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy;Molecular Cancer;2024-08-02

4. A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule;Pharmaceutics;2024-05-15

5. Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses;International Journal of Molecular Sciences;2024-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3